@incollection{, F7D4D35113DE20D796DF2CA4483605B3 , author={{Dr. AmrGuenedi} and {Dr. YousifObeid} and {Sultan Qaboos University}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1411114 } @incollection{b0, , title={{}} , journal={{World health organization}} } @incollection{b1, , title={{}} , journal={{Boronow J (Psychiatr Serv}} 52 , year={October 2001} } @book{b2, , title={{}} , author={{ DsmIv }} } @incollection{b3, , title={{Side effect profiles of new antipsychotic agents. Casey DE}} , journal={{J Clin Psychiatry}} 57 11 , year={1996} , note={Suppl} } @book{b4, , title={{Olanzapine: a new typical antipsychotic drug. Meltzer HY, Fibiger HC. Neuropsychopharmacology}} , year={1996 Feb} 14 } @incollection{b5, , title={{A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses}} , author={{ Olanzapine }} , journal={{Drugs}} 53 2 , year={1997 Feb} } @book{b6, , title={{Antipsychotic polypharmacy: is there evidence for its use?}} , author={{ VPatrick } and { LevinESchleifer } and { SPsychiatr Pract }} , year={2005 Jul} 11 } @incollection{b7, , title={{Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review}} , journal={{Newcomer JW. CNS Drugs}} 19 1 , year={2005} , note={Suppl} } @incollection{b8, , title={{Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study}} , author={{ MLambert } and { PConus } and { BGSchimmelmann } and { PEide } and { JWard } and { HYuen } and { MSchacht } and { JEdwards } and { DNaber } and { McGorry } and { PD }} , journal={{Pharmacopsychiatry}} 38 5 , year={2005 Sep} } @incollection{b9, , title={{Olanzapine versus risperidone in newly admitted acutely ill psychotic patients}} , author={{ JEKraus } and { BBSheitman } and { ACook } and { RReviere } and { JALieberman }} , journal={{J Clin Psychiatry}} 66 12 , year={2005 Dec} } @incollection{b10, , title={{Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy}} , author={{ RMCarnahan } and { BCLund } and { PJPerry } and { EAChrischilles }} , journal={{Acta Psychiatr Scand}} 113 2 , year={2006 Feb} } @incollection{b11, , title={{A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis}} , author={{ BCrespo-Facorro } and { RPérez-Iglesias } and { MRamirez-Bonilla } and { OMartínez-García } and { JLlorca } and { LuisVázquez-Barquero } and { J }} , journal={{J Clin Psychiatry}} 67 10 , year={2006 Oct} } @incollection{b12, , title={{Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia}} , author={{ REMccue } and { RWaheed } and { LUrcuyo } and { GOrendain } and { MDJoseph } and { RCharles } and { SMHasan }} , journal={{Br J Psychiatry}} 189 , year={2006 Nov} } @incollection{b13, , title={{Selecting patients for long-acting novel antipsychotic therapy}} , author={{ Muller }} , journal={{Australasian Psychiatry}} 14 , year={March 2006} } @incollection{b14, , title={{Does risperidone have a place in treatment of nonschizophrenic patients? International}} , author={{ ISchweitzer }} , journal={{Clinical Psychopharmacology}} 16 , year={2001} } @book{b15, , author={{ SStahl }} , title={{Essential pharmacology of antipsychotics and mood stabilizers}} , publisher={Cambridge university press} , year={200.2} } @book{b16, , title={{}} , author={{ SStahl }} 2002 } @book{b17, , title={{The prescriber's guide: antipsychotics and mood stabilizers}} , author={{ SStahl }} , year={2006} , publisher={Cambridge university press} } @book{b18, , title={{}} , author={{ StephenEssentials Of Psychopharmacology } and { Stahl }} , year={2009} } @book{b19, , title={{Amen D: Functional neuroanatomy}} }